Best Squamous Cell Carcinoma Podcasts (2024)

1
An Introduction to Squamous Cell Carcinoma of the Head and Neck

6d ago

—

Guest: Lori J. Wirth, MD Head and neck cancers are the seventh most common cancers globally and are increasing in prevalence.1,2 To dive further into the intricacies of this early-stage cancer, join Dr. Lori Wirth, Medical Oncologist in the Head and Neck Oncology Program at Massachusetts General Hospital in Boston. References: Gormley M, et al. Br …

1
Skin Cancers and Treatments Basics | Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma, Merckel Cell Carcinoma 8:31

17d ago8:31

8:31

Hear from Board Certified Dermatologist Dr. Rebecca Baxt about the common forms of skin cancer and the typical treatment protocols.By Dr. Rebecca Baxt

1
The Power of Patient Advocacy in Daily Clinical Practice

1d ago

—

Guest: Ashley L. Sumrall, MD Advocacy is rooted in patients telling their stories, and every patient can be an advocate to help and allow others to hear about their experience. This has also helped clinicians get the medicine they need for their patients. Dive in to hear how you can incorporate advocacy strategies into your practice with Dr. Ashley…

1
The Impact of Advocacy on Healthcare

1d ago

—

Guest: Ashley L. Sumrall, MD If we want to ensure that we and our patients have healthcare when we’re older and it continues to be available, it’s important to take a stand and be a part of advocacy work. There are multiple ways to get involved, and it’s not as intimidating as someone might think, so to share some of these strategies and the impact…

1
Updates on New Technologies and Imaging Agents in Healthcare

1d ago

—

Guest: Tyler J Bradshaw, PhD In recent years, doctors have become interested in how large language models and AI technologies could potentially improve radiology overall. Even though these technologies are still in the beginning stages of being used in medicine, eventually doctors hope to show what impact they could have on patients. To learn more …

1
Treating Breakthrough PONV: A Review of Therapeutic Approaches, Considerations, and Guidelines

1d ago

—

Guest: TJ Gan, MD, MBA, MHS, FRCA (UK), FRCA (lre), LicAc Guest: Dru Riddle, PhD, DNP, CRNA When it comes to postoperative nausea and vomiting (PONV) management, multimodal, antiemetic therapy based on patients’ risk factors is routinely provided to minimize the incidence, but unfortunately, patients may still develop breakthrough PONV, in which an…

1
Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned

16h ago

—

Host: Joseph Kim, MD, MPH This video brief will discuss quality improvement in myelofibrosis management. To highlight ways to improve care for patients with both primary and secondary myelofibrosis, we’ll examine the experiences of two cancer centers that engaged in quality improvement programs. Molecular Testing Symptom Assessment Prognostic Risk …

1
205 - Empowerment in Midlife: Revealing Your Potential with Joe Hoye 26:09

1d ago26:09

26:09

Explore the key components of designing your ideal life. Host Amy Ledin introduces Joe Hoye, a renowned fitness expert spearheading a summit on perimenopause, menopause, and overall well-being. Joe shares his transformative journey, ignited at age 13 by his mother's introduction to the gym, propelling him into a career in surgical technology with a…

1
A Pre-Conference Perspective of SNMMI 2024

2d ago

—

Tune in ahead of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Annual Meeting in Toronto for a preview of what to expect with Dr. Munir Ghesani, Chief Medical Officer and the Medical Director at United Theranostics in Princeton, New Jersey.

1
An Introduction to Squamous Cell Carcinoma of the Head and Neck

8d ago

—

Guest: Lori J. Wirth, MD Head and neck cancers are the seventh most common cancers globally and are increasing in prevalence.1,2 To dive further into the intricacies of this early-stage cancer, join Dr. Lori Wirth, Medical Oncologist in the Head and Neck Oncology Program at Massachusetts General Hospital in Boston. References: Gormley M, et al. Br …

1
ABCDEs of Skin Cancer | Self Skin Exam, Moles 6:29

3d ago6:29

6:29

Dr. Rebecca Baxt Discusses what to look for on your own self skin exam and reviews the ABCDEs of skin cancer.By Dr. Rebecca Baxt

1
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups

8d ago

—

Host: Jennifer Caudle, DO Guest: Joyce O'Shaughnessy, MD The results from the phase III EMERALD trial led to the approval of ORSERDU® (elacestrant) as the first oral selective estrogen receptor degrader for ER-positive/HER2-negative metastatic breast cancer patients with ESR1 mutations after disease progression following at least one line of endocr…

1
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups

14d ago

—

Host: Jennifer Caudle, DO Guest: Joyce O'Shaughnessy, MD The results from the phase III EMERALD trial led to the approval of ORSERDU® (elacestrant) as the first oral selective estrogen receptor degrader for ER-positive/HER2-negative metastatic breast cancer patients with ESR1 mutations after disease progression following at least one line of endocr…

1
The Value of CINtec® PLUS Cytology Test in Cervical Cancer Screening

16d ago

—

Host: Jennifer Caudle, DO Guest: Tamera A. Paczos, MD, FACOG, FACP The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A…

1
Poster Pearl: A 2-Biomarker Class MCED Test Delivers High Specificity and Sensitivity

23d ago

—

Host: Brian P. McDonough, MD, FAAFP Guest: Frank Diehl, PhD A poster presented at the 2024 American Association for Cancer Research Annual Meeting showcased findings from the ASCEND 2 study, which examined the performance of a multi-cancer early detection (MCED) test design that included methylation and protein biomarkers. The study found that this…

1
204 - Six Reasons You Should Rehearse Your Day 13:54

21d ago13:54

13:54

Discover how a simple five-minute nightly routine can transform your day with reduced stress and heightened efficiency. Host Amy Ledin shares personal insights and actionable strategies for implementing this practice, emphasizing the benefits of detailed planning for daily tasks and nutrition. She explains how mentally rehearsing your day can help …

1
Diagnostic and Treatment Dilemmas in Polymyalgia Rheumatica

24d ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: William F.C. Rigby, MD Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition that can be difficult to diagnose and treat. For instance, PMR is a diagnosis of exclusion, and it can mimic a wide variety of other conditions. And once a patient is accurately diagnosed, the standard-of-care t…

1
Investigating HLH: Our Current Understanding of a Rare Disease

1M ago

—

Guest: Adam Narloch Guest: Michelle Hermiston, MD, PhD Adam Narloch speaks with Dr Michelle Hermiston to discuss the history of hemophagocytic lymphohistiocytosis (HLH) and advances in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the Director of the Pediatric Immunoth…

1
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer

30d ago

—

Host: Javier Cortes, MD, PhD Guest: Komal Jhaveri, MD, FACP The addition of antibody-drug conjugate (ADC) therapies to the treatment armamentarium for endocrine-refractory, HR-positive, HER2-negative metastatic breast cancer has greatly improved outcomes for patients in this setting. However, selecting the appropriate ADC and determining the optima…

1
What to Expect at Your Skin Cancer Screening | Board Certified Dermatologist, Skin Exam 6:29

1M ago6:29

6:29

Board Certified Dermatologist Dr. Rebecca Baxt reviews what takes place at a skin cancer screening, so you know before you go!By Dr. Rebecca Baxt

1
203 - A Mother's Love Beyond Loss 43:28

1M ago43:28

43:28

Embark on a journey of understanding, solace, and resilience as we explore grief, faith, and the human spirit. Host Amy Ledin graciously welcomes Sarah Prebianca to the podcast. Together, they have unraveled Sarah's remarkable story—a testament to resilience in the face of unimaginable loss, her daughter Georgia taken by a rare disease. Through Sar…

1
Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens

1M ago

—

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They discuss optimizing first-line immunotherapeutic regimens, using biomarkers to determine response to immunother…

1
Overcoming Barriers to Equitable Care in HNSCC

1M ago

—

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They discuss optimizing first-line immunotherapeutic regimens, using biomarkers to determine response to immunother…

1
Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC

1M ago

—

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They discuss optimizing first-line immunotherapeutic regimens, using biomarkers to determine response to immunother…

1
The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence

1M ago

—

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They discuss optimizing first-line immunotherapeutic regimens, using biomarkers to determine response to immunother…

1
Managing Immune-Related Adverse Events With Immunotherapies

1M ago

—

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They discuss optimizing first-line immunotherapeutic regimens, using biomarkers to determine response to immunother…

Podcasts Worth a Listen

Squamous Cell Carcinoma Podcasts

Podcasts Worth a Listen

Quick Reference Guide